HB90 (2021) Detail

Allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.


HB 90  - AS INTRODUCED

 

 

2021 SESSION

21-0085

04/11

 

HOUSE BILL 90

 

AN ACT allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

 

SPONSORS: Rep. Vail, Hills. 30; Rep. Laflamme, Coos 3

 

COMMITTEE: Health, Human Services and Elderly Affairs

 

-----------------------------------------------------------------

 

ANALYSIS

 

This bill allows alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

21-0085

04/11

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty One

 

AN ACT allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  New Paragraph; Use of Cannabis for Therapeutic Purposes; Alternative Treatment Centers; Requirements.  Amend RSA 126-X:8 by inserting after paragraph XVIII the following new paragraph:

XIX.  An alternative treatment center may acquire, and may use in the manufacture of cannabis concentrate and cannabis infused products, hemp-derived cannabidiol, or CBD, isolate that is not produced by an alterative treatment center in New Hampshire.  All such CBD isolate, and all cannabis concentrate and cannabis infused products manufactured from such CBD isolate, shall be tested for contaminants and cannabinoid profile in accordance with this chapter and department rules.

2  Effective Date.  This act shall take effect 60 days after its passage.

Links

HB90 at GenCourtMobile
HB90 Discussion

Action Dates

Date Body Type
Feb. 23, 2021 House Hearing
House Floor Vote

Bill Text Revisions

HB90 Revision: 31378 Date: Jan. 4, 2021, 11:25 a.m.

Docket


: Committee Report: Inexpedient to Legislate (Vote 20-0; CC)


Feb. 23, 2021: Public Hearing: 02/23/2021 09:45 am Members of the public may attend using the following link: To join the webinar: https://www.zoom.us/j/95885653389 / Executive session on pending legislation may be held throughout the day (time permitting) from the time the committee is initially convened.


Jan. 6, 2021: Introduced (in recess of) 01/06/2021 and referred to Health, Human Services and Elderly Affairs HJ 2 P. 34


Jan. 6, 2020: To Be Introduced 01/06/2020 and referred to Health, Human Services and Elderly Affairs